- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/32 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products from oncogenes
Patent holdings for IPC class C07K 16/32
Total number of patents in this class: 3934
10-year publication summary
|
297
|
403
|
339
|
354
|
368
|
396
|
377
|
353
|
344
|
215
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Genentech, Inc. | 3972 |
162 |
| Hoffmann-La Roche Inc. | 3408 |
107 |
| F. Hoffmann-La Roche AG | 7930 |
83 |
| Zymeworks Inc. | 256 |
49 |
| Daiichi Sankyo Company, Limited | 1862 |
45 |
| Amgen Inc. | 4073 |
44 |
| Merus N.V. | 212 |
44 |
| Mayo Foundation for Medical Education and Research | 3202 |
43 |
| Genmab A/S | 416 |
43 |
| The Trustees of the University of Pennsylvania | 4317 |
41 |
| Regeneron Pharmaceuticals, Inc. | 4252 |
37 |
| Memorial Sloan-Kettering Cancer Center | 1925 |
33 |
| Sanofi | 4040 |
33 |
| Centre National de La Recherche Scientifique | 10418 |
30 |
| Dragonfly Therapeutics, Inc. | 134 |
30 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3367 |
28 |
| Board of Regents, The University of Texas System | 5782 |
27 |
| Sutro Biopharma, Inc. | 170 |
27 |
| Novartis AG | 10856 |
25 |
| Immatics Biotechnologies GmbH | 1156 |
25 |
| Other owners | 2978 |